Phil Stephens,
Chief Scientific Officer
Dr. Stephens leads research and development at Foundation Medicine. Dr. Stephens is a world-renowned expert in next-generation sequencing and cancer genome analysis and has authored numerous publications in Nature, Nature Genetics, Nature Medicine, Cell and other high-profile journals. Since joining Foundation Medicine in early 2011 Dr Stephens has overseen the development of FoundationOne™, and FoundationOne™ Heme, comprehensive next generation sequencing diagnostic assays that accurately profiles the entire coding sequence of hundreds of cancer-related genes in the CLIA setting. Prior to joining Foundation Medicine, Dr. Stephens held various senior research positions during his 11-year tenure with the Cancer Genome Project at the Wellcome Trust Sanger Institute under the direction of Sir Professor Michael Stratton.
|
|
|
